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Introduction 
Aortic graft infection is the most feared and cata- 
strophic complication of vascular econstructive sur- 
gery, presenting rave risks to life and limb of the 
patients. Fortunately its incidence is low, ap- 
proximating 2% in most reported series. 1'2 In the area 
of treatment one is faced with many choices, including 
extra-anatomic bypass as a staged or combined pro- 
cedure, in situ graft replacement and conservative non- 
resectional therapy. 
The majority of authors still prefer preliminary 
axillofemoral bypass through clean tissue followed by 
aortic graft excision as surgical method of choice in the 
treatment of aortic graft infection, and have reported 
mortality rates ranging from 10-25% achieved by this 
method, and morbidity in form of amputation in ap- 
proximately 30% of patients in whom aortic graft 
infection does occur. 3-7 
This report deals with our experience with pre- 
liminary axillobifemoral bypass for the management 
of infected aortobifemoral bypass, with special em- 
phasis on methods of diagnosis, graft culture result, 
subsequent axillobifemoral graft infection, amputation 
rate and follow-up survival. 
Patients and Methods 
who subsequently developed graft infection were non- 
ruptured abdominal aortic aneurysm in two, and sten- 
oses/occlusions of the aortoiliac region in five (Table 1). 
All operations were performed via the transperitoneal 
route. At the time of the primary operation we did 
not investigate the bacteriology of the aneurysm con- 
tents or arterial wall. However, all patients received 
peroperative antibiotics. All the grafts used were knit- 
ted Dacron. 
Diagnostic studies in evaluating aortobifemoral graft 
infection were computed tomography (CT) scan and 
ultrasound, which was performed in all patients and 
demonstrated perigraft fluid in five patients (Fig. 1) 
Indium labelled white blood cell scan demonstrated 
increased uptake within a portion of the aortic bi- 
furcation graft in three of five patients tudied. Blood 
culture was only positive in two patients, contrast 
sinography was utilised in another two cases and 
was diagnostic for graft infection both times (Fig. 2). 
Preoperative angiography was used to assure patient 
femoropopliteal segments, for technical feasibility of 
axillofemoral bypass, and for detection of aortoenteric 
fistula, which was also diagnosed by gastroscopy in 
two cases (Table 2). Graft infection presented as gastro- 
intestinal bleeding caused by aortoenteric fistula in 
two patients and infected groins in the other five cases. 
Gastrointestinal bleeding was not life-threatening, so 
that a staged operation could be planned. All seven 
patients presented with fever and leukocytosis. The 
In a retrospective analysis seven patients treated for 
aortobifemoral vascular graft infection between 1985 
and 1995 were evaluated. There were six males and 
one female, with a mean age of 63 years. The total 
number of primary aortobifemoral bypass procedures 
performed within the observation time was 785, re- 
sulting in an incidence of 1.1% for aortic graft infection, 
compared to 2% in most reported series. 1,2 The in- 
dication for the primary operation in the seven patients 
Table 1. Indications for primary operation and type of aortic 
anastomosis n seven patients who subsequently developed aortic 
graft infection. 
Indication Type of anastomosis 
Abdominal ortic aneurysm 2 EEA 6 
Stenosis 
Occlusion 5 ESA 1 
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Fig. 1. Positive CT-scan showing fluid collection around the aortic graft. 
interval between the initial operation and the oc- 
currence of symptoms of graft infection ranged from 
1 month to 11 years (Table 3) 
Surgical management of the infected aortic graft 
consisted of a staged axillobifemoral prosthetic graft 
through clean tissue 3-6 days prior to aortic graft 
excision. In all patients, knitted Dacron grafts were 
used for the extra-anatomic procedure. At the second 
operation the infected aortic graft was removed to- 
gether with an adequate aortic wall debridement, 
which included all grossly infected and devitalised 
tissue prior to aortic stump closure in two layers using 
a large monofi lament suture. If possible, omentum 
was utilised as vascularised tissue coverage for the 
aortic stump. By performing this technique we avoided 
stump disruption and retrograde aortic thrombosis 
with renal failure. The organisms which were cultured 
from the infected graft were Staphylococcus aureus in 
five, enterococcus in one and Escherichia coli in one 
patient (Table 3). 
Fig. 2. Positive sinogram obtained by left groin tract injection, 
showing filling of the left perigraft limb space and tracking su- 
periorly to aortic stump. 
Table 2. Diagnostic studies in seven patients presenting with 
aortic graft infection. 
Study No. Performed No. Positive 
CT-scan 7 5 
Ultrasound 7 4 
Blood Culture 7 2 
Indium 111 labelled WBC scan 5 3 
Angiography 7 
Gastroscopy 3 2 
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Table 3. Summary of patients' data. 
Patient Symptoms Organisms Interval Outcome 
F,J. 57 Gastrointestinal bleeding S. aureus 11 years Death 
K.M. 64 Groin mass S. aureus 4 years Death 
G.K. 66 Groin mass S. aureus 7 years Death 
W.F. 63 Groin mass S. aureus 8 years Death 
H.J. 71 Gastrointestinal bleeding E. coli 2 years Death 
S.H. 57 Groin mass Enterococcus 2 years Death 
W.A. 61 Groin mass S. aureus 1 month Death 
Table 4. Summary of patients' data. 
Surg treatment Major Cause of death Time of 
amputation survey 
AFB graft excision staged No 
AFB graft excision staged Yes 
AFB graft excision staged Yes 
AFB graft excision staged No 
AFB graft excision staged No 
AFB graft excision staged Yes 
AFB graft excision staged Yes 
Multiorgan failure 1 month 
Pulmonary embolism 1 month 
Septicaemia 9 months 
Myocardial infarction 7 months 
Myocardial infarction 10 months 
Septicaemia 6 months 
Septicaemia 5 months 
Results 
The postoperative r sults and the follow-up survival 
in our series are very disappointing, as all patients 
died within 10 months. One patient died from multi- 
organ failure after I month and two patients died from 
myocardial infarction. These three patients howed no 
symptoms of axillobifemoral graft infection. The other 
four patients developed subsequent axillobifemoral 
graft infection. The interval from initial placement of 
the axillobifemoral graft o diagnosis of axillobifemoral 
graft infection was 2 weeks, 3, 5 and 7 months. Axillo- 
bifemoral graft infection was managed by graft ex- 
cision in all patients and a subsequent autogenous 
revascularisation using the saphenous vein and muscle 
flap coverage. Nevertheless, those four patients had 
to undergo a mean of three further operations due to 
vein graft thrombosis of the autogenous vein, even- 
tually resulting in amputation, two of them requiring 
hip disarticulation  both sides. Finally, three patients 
died of septicaemia and one of pulmonary embolism 
(Table 4). 
Discussion 
The reviews for aortic graft infection managed by sta- 
ging extra-anatomic bypass followed by aortic graft ex- 
cision report a mortality of 21%, amputation rate of 11% 
and extra-anatomic bypass graft sepsis of 18%. ~7 If the 
graft excision proceeds extra-anatomic bypass, the mor- 
tality is 26%, and the amputation rate increases to 46% 
accompanied by extra-anatomic bypass graft sepsis in 
23%. 6'8-11 The reported incidence of prosthetic graft infec- 
tion is approximately 0.5% for the aortoiliac 9'12 
2% for the aortofemoral, 13 1% for axillofemora112'14 
and 2.5% for the femoropopliteal grafts. Vascular graft 
infection can be reduced by using prophylactic intra- 
venous antibiotics because new culture techniques have 
revealed a high incidence of positive cultures from clin- 
ically uninfected aneurysm contents or arterial wall: 
13% in abdominal ortic aneurysms ~5'~6 and 54% in fem- 
oral pseudoaneurysms. 17 Careful technique during the 
original procedure and careful separation of the ab- 
dominal aortic graft from the bowel have also been pro- 
posed to reduce the risk of aortic graft infection. Many 
authors have identified multiple previous vascular pro- 
cedures, wound complications and emergency ab- 
dominal aneurysmectomy as possible predisposing 
factors for aortic graft infection. 6'9'1s 
Common symptoms of aortic graft infection are 
fever and/or leukocytosis in 42-53% of patients, 9'n 
inguinal wound infection or draining sinus in 38-45% 
and gastrointestinal bleeding caused by aortoenteric 
fistula which was observed both by O'Hara et al. and 
Yeager et al. in 37% of their patients. 9'n Occasionally 
graft infection underlies a silent graft occlusion or is 
heralded by the apppearance of a false aneurysm. 6 
The diagnosis of an infected aortic graft is most 
commonly made by the appearance of the involved 
wound.  
Computed tomography scan, labelled white blood 
cell scans, ultrasound and contrast sinography are 
used to investigate occult and limited graft infect ion. 19'20 
Preliminary data suggest that magnetic resonance im- 
aging (MRI) may be a useful addition in the area 
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of diagnosis. Both the indium-labelled leukocyte and 
immunoglobulin scans appear promising for early 
diagnosis. In clinically obvious aortic graft infection a 
major problem remains estimation of the extent of the 
graft infection. In many cases operative inspection of 
the graft is necessary to rule out or to confirm infection. 
One is faced with many choices for the treatment 
of infected aortic grafts. Standard excisional therapy 
in conjunction with axillofemoral bypass appears to 
be an effective and durable solution to this difficult 
surgical problem. The performance of axillofemoral 
grafting prior to aortic graft removal is preferred by 
most authors.  6'9'21 Performing the extra-anatomic by- 
pass first enables the surgeon to focus on aortic de- 
bridement and closure without concern about ongoing 
lower extremity ischaemia. Obviously some patients 
presenting with acute gastrointestinal bleeding will 
require initial emergency graft excision. O'Hara et 
al. noted significantly fewer amputations in staged 
procedures than in simultaneous treatment requiring 
aortic graft excision and extra-anatomic bypass. 9 Reilly 
et al. noted similar results in terms of mortality, am- 
putation rate and incidence of new graft infection 
whether the extra-anatomic bypass was performed 
immediately, before or several days prior to aortic 
graft excision. 6 A two-staged operation seems also to 
reduce the risk of bacterial colonisation of the newly 
implanted axillofemoral bypass during the removal of 
the infected aortic graft. 
Although some authors have achieved good long- 
term results, using axillofemoral bypass for aortic graft 
infection 4 our results were devastating, mainly due 
to the fatal outcome of infection of the subsequent 
axillofemoral bypass graft. Many authors have noted 
that a significantly higher amputation rate occurs in 
those patients who develop subsequent extra-anatomic 
graft infection compared with those who do not. 6'9'11 
The cause of extra-anatomic bypass infection in those 
patients is unclear but may relate to the patients' 
septic focus or perhaps to operative technique during 
demanding emergency operations. Yeager et al. re- 
ported a higher percentage of infected Dacron axillo- 
femoral bypass grafts compared with PTFE grafts, but 
the difference was not significant. 11Rifampicin-bonded 
Dacron grafts 22 and ofloxacin PTFE grafts 23 may also 
be more resistant to infection. 
The management of infected axillofemoral graft in- 
cludes total or partial graft excision, non-resectional 
therapy with debridement, muscle flap coverage or 
continuous povidone-iodine irrigation. 24-26 Several op- 
tions exist for revascularisation following removal of 
an infected axillofemoral bypass, including auto- 
genous reconstruction. Revascularisation is necessary 
if the axillofemoral bypass is patent or if the occluded 
axillofemoral bypass has rendered the extremity isch- 
aemic. Autogenous reconstruction using saphenous 
vein or endarterectomised superficial femoral artery 
avoids the use of prosthetic tissue but carries a sig- 
nificant risk of early thrombosis. 
Conclusion 
Prevention of aortic graft sepsis eliminates the need 
for treatment, which carries a high morbidity and 
mortality. As most aortic graft infections are due to a 
contamination at the time of implantation 2, aseptic 
technique, prophylactic anti-staphylococcal antibiotic 
treatment and careful separation of the aortic graft 
from the bowel should be emphasised. 
There seems to be consensus that the "gold stand- 
ard" for patients with aortic graft infection includes 
complete removal of the infected graft, and extra- 
anatomic revascularisation. However, in our hands the 
results of this management policy have been dis- 
appointing. In situ replacement by antibiotic bonded 
grafts and non-resectional treatment by antiseptic/ 
antibiotic irrigation are promising alternatives. 
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